BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35890076)

  • 1. Exploring the Anticancer Effects of Brominated Plastoquinone Analogs with Promising Cytotoxic Activity in MCF-7 Breast Cancer Cells via Cell Cycle Arrest and Oxidative Stress Induction.
    Jannuzzi AT; Yilmaz Goler AM; Bayrak N; Yıldız M; Yıldırım H; Karademir Yilmaz B; Shilkar D; Venkatesan RJ; Jayaprakash V; TuYuN AF
    Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer.
    Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
    Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer agents based on Plastoquinone analogs with N-phenylpiperazine: Structure-activity relationship and mechanism of action in breast cancer cells.
    Jannuzzi AT; Yıldız M; Bayrak N; Yıldırım H; Shilkar D; Jayaprakash V; TuYuN AF
    Chem Biol Interact; 2021 Nov; 349():109673. PubMed ID: 34560069
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Yilmaz Goler AM; Jannuzzi AT; Bayrak N; Yıldız M; Yıldırım H; Otsuka M; Fujita M; Radwan MO; TuYuN AF
    ACS Omega; 2022 Aug; 7(34):30250-30264. PubMed ID: 36061710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling.
    Jannuzzi AT; Yilmaz Goler AM; Shilkar D; Mondal S; Basavanakatti VN; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
    Chem Biol Drug Des; 2023 Nov; 102(5):1133-1154. PubMed ID: 37537000
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Ciftci H; Sever B; Bayrak N; Yıldız M; Yıldırım H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Silico Study of Analogs of Plant Product Plastoquinone to Be Effective in Colorectal Cancer Treatment.
    Ciftci H; Sever B; Ocak F; Bayrak N; Yıldız M; Yıldırım H; DeMirci H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis.
    Elanany MA; Osman EEA; Gedawy EM; Abou-Seri SM
    Sci Rep; 2023 Mar; 13(1):4144. PubMed ID: 36914702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of potential anticancer agents and apoptotic inducers based on 4-aryl-4H chromene scaffold: Design, synthesis, biological evaluation and insight on their proliferation inhibition mechanism.
    Elshemy HAH; Zaki MA; Mahmoud AM; Khan SI; Chittiboyina AG; Kamal AM
    Bioorg Chem; 2022 Jan; 118():105475. PubMed ID: 34800886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
    Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
    Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinamide derivatives of melampomagnolide B and their anti-cancer activities.
    Janganati V; Ponder J; Thakkar S; Jordan CT; Crooks PA
    Bioorg Med Chem; 2017 Jul; 25(14):3694-3705. PubMed ID: 28545815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAF
    Ali EMH; Mersal KI; Ammar UM; Zaraei SO; Abdel-Maksoud MS; El-Gamal MI; Haque MM; Das T; Kim EE; Lee JS; Lee KH; Kim HK; Oh CH
    Eur J Pharm Sci; 2022 Apr; 171():106115. PubMed ID: 34995782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
    Penthala NR; Ketkar A; Sekhar KR; Freeman ML; Eoff RL; Balusu R; Crooks PA
    Bioorg Med Chem; 2015 Nov; 23(22):7226-33. PubMed ID: 26602084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
    Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
    Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and identification of novel selective antitumor constituents, sidrin and sidroside, from
    Mostafa MAH; Khojah HMJ; Ohta T
    Saudi Pharm J; 2023 Jun; 31(6):1019-1028. PubMed ID: 37234346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.
    Sabt A; Eldehna WM; Al-Warhi T; Alotaibi OJ; Elaasser MM; Suliman H; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1616-1630. PubMed ID: 32781872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.